comparemela.com

Latest Breaking News On - Cell therapy program - Page 8 : comparemela.com

Dr Lin on the Outcomes of MRD-Negative Patients With R/R Myeloma After Cilta-Cel

Yi Lin, MD, PhD, discusses the patient characteristic for those with relapsed/refractory multiple myeloma who experienced sustained minimal residual disease negativity following treatment with ciltacabtagene autoleucel during the phase 1/2 CARTITUDE-1 trial.

Researchers uncover mysteries behind immune response to hemophilia A treatment

Researchers uncover mysteries behind immune response to hemophilia A treatment
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.